See more : Consumer Automotive Finance, Inc. (NWAU) Income Statement Analysis – Financial Results
Complete financial analysis of Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Asia Medical and Agricultural Laboratory and Research Center Public Company Limited, a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
- Paramount Global (VIAC) Income Statement Analysis – Financial Results
- Wuling Motors Holdings Limited (WLMTF) Income Statement Analysis – Financial Results
- Relevant Gold Corp. (RGCCF) Income Statement Analysis – Financial Results
- Bearing Lithium Corp. (BRZ.V) Income Statement Analysis – Financial Results
- ARYZTA AG (ARZTF) Income Statement Analysis – Financial Results
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC.BK)
About Asia Medical and Agricultural Laboratory and Research Center Public Company Limited
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides laboratory services for the agriculture, food, and pharmaceutical industries in Thailand. The company offers testing, inspection, and certification services for meat and meat products, fats and oils, pet food, feedstuffs and feed raw materials, aquaculture, aquatic animals and aquatic animal products, crops, foods, beverages, water ice, potable water, water, air, and soil; quality control and registration services for fertilizers; quality control, efficacy test, and residue trial and registration services for hazardous substances; and efficacy and residue trial test of pesticides for registration. It also provides quality assurance testing, and research and development services for drugs and raw materials; analysis of components in pharmaceutical products; drug analysis method validation; bioequivalence studies; and quality assurance with contaminant and challenge tests for cosmetics, as well as develops test methods for pharmaceutical products. In addition, the company offers calibration services for electrical and temperature, chemical, and mechanical metrology, as well as for various medical devices, such as electrocardiograms, non-invasive blood pressure devices, patient monitors, pulse oximeters, and electrical safety analyzers; and consultation and training services, which include preparation services for quality system, inspection, certification, and ISO/IEC 17025 and quality system, as well as manages and optimizes tools and equipment. Further, it provides nutrition labeling and shelf-life testing services, and food contact materials. The company was founded in 2004 and is headquartered in Bangkok, Thailand. Asia Medical and Agricultural Laboratory and Research Center Public Company Limited is a subsidiary of Ladprao General Hospital Public Company Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 289.21M | 263.22M | 245.95M | 219.74M | 197.75M | 163.41M |
Cost of Revenue | 180.74M | 158.17M | 139.05M | 122.05M | 123.35M | 106.07M |
Gross Profit | 108.47M | 105.05M | 106.91M | 97.68M | 74.40M | 57.34M |
Gross Profit Ratio | 37.51% | 39.91% | 43.47% | 44.45% | 37.62% | 35.09% |
Research & Development | 0.00 | 18.44M | 19.94M | 10.29M | 0.00 | 0.00 |
General & Administrative | 76.68M | 65.98M | 53.78M | 43.15M | 58.44M | 51.26M |
Selling & Marketing | 20.65M | 15.99M | 15.28M | 15.80M | 16.01M | 17.96M |
SG&A | 97.33M | 81.98M | 69.06M | 58.95M | 52.71M | 50.60M |
Other Expenses | 0.00 | -1.04M | 3.48M | 5.10M | 0.00 | 0.00 |
Operating Expenses | 97.66M | 80.93M | 72.53M | 64.05M | 52.71M | 50.60M |
Cost & Expenses | 278.40M | 239.10M | 211.58M | 186.10M | 176.05M | 156.67M |
Interest Income | 0.00 | 6.17M | 6.89M | 4.53M | 3.11M | 2.50M |
Interest Expense | 2.83M | 6.17M | 6.89M | 4.53M | 3.11M | 0.00 |
Depreciation & Amortization | 37.09M | 33.50M | 28.98M | 22.27M | 14.77M | 12.47M |
EBITDA | 52.87M | 57.62M | 63.35M | 55.91M | 36.75M | 20.55M |
EBITDA Ratio | 18.28% | 21.89% | 25.76% | 25.44% | 18.44% | 11.75% |
Operating Income | 15.78M | 24.12M | 34.37M | 33.64M | 21.69M | 6.74M |
Operating Income Ratio | 5.46% | 9.16% | 13.97% | 15.31% | 10.97% | 4.13% |
Total Other Income/Expenses | -3.16M | -6.17M | -6.89M | -4.53M | -2.82M | -1.16M |
Income Before Tax | 12.61M | 17.94M | 27.48M | 29.11M | 18.87M | 5.58M |
Income Before Tax Ratio | 4.36% | 6.82% | 11.17% | 13.25% | 9.54% | 3.41% |
Income Tax Expense | 2.97M | 3.43M | 2.62M | 683.80K | 679.87K | 1.86M |
Net Income | 9.64M | 14.52M | 24.86M | 28.43M | 18.19M | 3.72M |
Net Income Ratio | 3.33% | 5.51% | 10.11% | 12.94% | 9.20% | 2.28% |
EPS | 0.02 | 0.04 | 0.21 | 0.24 | 0.15 | 0.03 |
EPS Diluted | 0.02 | 0.04 | 0.21 | 0.24 | 0.15 | 0.03 |
Weighted Avg Shares Out | 420.00M | 326.96M | 120.00M | 120.00M | 120.00M | 120.00M |
Weighted Avg Shares Out (Dil) | 420.00M | 326.96M | 120.00M | 120.00M | 120.00M | 120.00M |
Source: https://incomestatements.info
Category: Stock Reports